Clevidipine Butyrate Powder CAS 167221-71-8 Raw Material

CAS: 167221-71-8

MF: C21H23Cl2NO6

MW: 456.32

EINECS: 682-702-2

Specification​: 99% min Clevidipine Butyrate

Sample:  Clevidipine Butyrate Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Portal:https://henrikang.en.made-in-china.com/

Clevidipine Butyrate Powder Usage and Synthesis.

Clevidipine Butyrate Powder is an innovative injectable anti-hypertensive drug for the treatment of acute hypertension with effects lasting up to 72 hours. Clevidipine Butyrate Raw Material, unlike existing hypertension drugs that are metabolized by the kidneys or liver, is metabolized in the blood and does not accumulate in the body. Clevidipine Butyrate CAS 167221-71-8 is a dihydropyridine calcium channel inhibitor used to lower blood pressure.

Application/Function of Clevidipine Butyrate Powder.

Clevidipine Butyrate is an innovative injectable anti-hypertensive drug, trade name: Cleviprex, for the treatment of acute hypertension with effects lasting up to 72 hours, which can be used when oral medication is ineffective or when the patient is not comfortable with oral medication, and which has a rapid onset of action. Unlike existing hypertension drugs that are metabolized by the kidneys or liver, clevidipine butyrate is metabolized in the blood and does not accumulate in the body, making it particularly useful for patients with advanced organ damage.

Pharmacological Effects of Clevidipine Butyrate Powder.

Clevidipine, a dihydropyridine derivative, is an ultra-short-acting intravenous calcium channel blocker that was developed by AstraZeneca as a short-term control of hypertension in the perioperative period, but development was discontinued for a time.

Covidipine is highly vascular and myocardial selective and is rapidly metabolized to inactive substances in the body. Covidipine has strong pulse rate lowering activity and also has a dilating effect on systemic and pulmonary vasculature.